🇮🇳IN
Sign In
LI

LINCOLN

NSE

Lincoln Pharmaceuticals Limited

₹504.35

-10.25(-1.99%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

LINCOLN shareholding summary

As of Sep 2026, promoters held 49.78% of Lincoln Pharmaceuticals Limited. Institutions together held 4.57%, of which foreign institutional investors held 4.55% (down 0.05 points from Jun 2026) and domestic institutions held 0.02% (down 0.25 points from Jun 2026). The public held the remaining 45.65% (up 0.29 points from Jun 2026). The company had 29,272 shareholders.

Promoters49.78%
FII4.55%
DII0.02%
Public45.65%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer